# A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion

> **NCT05669729** · — · NOT_YET_RECRUITING · sponsor: **Takeda** · enrollment: 60 (estimated)

## Conditions studied

- Gaucher Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05669729
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05669729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05669729, "A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05669729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*